3[1]Cohn DL,et al.Drug-resistant tuberculosis; review of worldwide situation and the WHO/IUATLD global surveillance project[J].Clin Infect Dis,1997,24 Supple.s121.
4[2]Sreevatsan S,et al.Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionary recent global dissemination[J].Proc Natl Acad Sci USA,1997,94:9869.
5[3]Kapur V,et al.Characterization by automated sequencing of mutations in the gene (rpoB)encoding the RNA polymerase B subunit the rifampin-resistant Mycobacterium tuberculosis strains from Mew York City and Texas[J].J Clin Microbiol,1994,32:1096.
6[4]Dribniewski FA,et al.The rapid diagnosis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis-a molecular story[J].J Med Microbiol,1998,47:189.
7[5]Sreevatsan S,et al.Characterization of rpsL and rrs mutation in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities[J].Antimicrob Agents Chemother,1996,40:1024.
8[6]sreevatsan S,et al.Ethambutol resistance in Mycobacterinu tuberculosis:Critical role of embB mutations[J].Antimicrob Agents Chemother,1997,41:1677.
9[7]Sreevatsan S,et al.Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms[J].Antimicrob Agents Chemother,1997,41:636.
10[8]Takiff HE,et al.Cloning and nucleotide sequence of the Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mechanism[J].Antimicrob Agents Chemother,1994,38:773.
